60 Degrees Pharmaceuticals to Sponsor Pilot Study of
60 Degrees Pharma (Nasdaq: SXTP) will sponsor a study using tafenoquine, an FDA-approved malaria drug, to treat canine babesiosis, a tick-borne disease....
Source: globenewswire.com
Materiel Development Activity News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Materiel Development Activity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Materiel Development Activity Today - Breaking & Trending Today
60 Degrees Pharmaceuticals Appoints Kristen Landon as Chief Commercial Officer
To lead U.S. commercial relaunch of ARAKODA® for malaria preventionWill support Company plan to expand clinical research strategy in tick-borne diseases beyond acute babesiosis WASHINGTON,...
Source: marketscreener.com
Positive Phase II Study Data Suggest ARAKODA® (tafenoquine) Numerically Improved Clinical Recovery in Patients with Mild-Moderate COVID-19 Disease
/PRNewswire/ -- Preliminary results of a phase II study of ARAKODA® (tafenoquine) for treatment of mild-moderate COVID-19 disease demonstrate a numerical...
Source: prnewswire.com